Global Biologic Medical Product Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biologic Medical Product Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Biologic Medical Product report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biologic Medical Product market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Tumor and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biologic Medical Product industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biologic Medical Product key companies include Roche, Amgen, AbbVie, Pfizer, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly and Novartis, etc. Roche, Amgen, AbbVie are top 3 players and held % share in total in 2022.
Biologic Medical Product can be divided into Monoclonal Antibodies, Colony-Stimulating Factor, Interferon and Erythropoietin, etc. Monoclonal Antibodies is the mainstream product in the market, accounting for % share globally in 2022.
Biologic Medical Product is widely used in various fields, such as Tumor, Diabetes, Cardiovascular and Hemophilia, etc. Tumor provides greatest supports to the Biologic Medical Product industry development. In 2022, global % share of Biologic Medical Product went into Tumor filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biologic Medical Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Roche
Amgen
AbbVie
Pfizer
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Ganlee
United Laboratories
Teva Pharmaceutical
MYLAN
Sun Pharma
Segment by Type
Monoclonal Antibodies
Colony-Stimulating Factor
Interferon
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologic Medical Product market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologic Medical Product introduction, etc. Biologic Medical Product Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biologic Medical Product market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Biologic Medical Product industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biologic Medical Product key companies include Roche, Amgen, AbbVie, Pfizer, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly and Novartis, etc. Roche, Amgen, AbbVie are top 3 players and held % share in total in 2022.
Biologic Medical Product can be divided into Monoclonal Antibodies, Colony-Stimulating Factor, Interferon and Erythropoietin, etc. Monoclonal Antibodies is the mainstream product in the market, accounting for % share globally in 2022.
Biologic Medical Product is widely used in various fields, such as Tumor, Diabetes, Cardiovascular and Hemophilia, etc. Tumor provides greatest supports to the Biologic Medical Product industry development. In 2022, global % share of Biologic Medical Product went into Tumor filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biologic Medical Product market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Roche
Amgen
AbbVie
Pfizer
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Ganlee
United Laboratories
Teva Pharmaceutical
MYLAN
Sun Pharma
Segment by Type
Monoclonal Antibodies
Colony-Stimulating Factor
Interferon
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
Segment by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologic Medical Product market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologic Medical Product introduction, etc. Biologic Medical Product Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biologic Medical Product market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.